Tag: hybrid trials

Case Studies: Hybrid Transition & Change Management That Improved Recruitment and Retention Case Studies: Hybrid Transition & Change Management That Improved Recruitment and Retention Decentralized and hybrid clinical trials are reshaping the landscape of pharmaceutical clinical trials by enabling greater flexibility in participant recruitment and retention. Realizing the full potential of hybrid models requires efficient…

Read More “Case Studies: Hybrid Transition & Change Management That Improved Recruitment and Retention” »

Patient-Centric Design Principles for Successful Hybrid Transition & Change Management Patient-Centric Design Principles for Successful Hybrid Transition & Change Management The transition from traditional clinical trial models to decentralized and hybrid clinical trials (DCTs) is reshaping the landscape of clinical research. Emphasizing patient-centric design principles is essential for successful implementation and change management. This article…

Read More “Patient-Centric Design Principles for Successful Hybrid Transition & Change Management” »

Hybrid Transition & Change Management: Operating Blueprint for Scalable Decentralized Trials Hybrid Transition & Change Management: Operating Blueprint for Scalable Decentralized Trials Introduction to Hybrid and Decentralized Clinical Trials The landscape of clinical trials is evolving rapidly, with a significant shift towards hybrid and decentralized clinical trial models. These methodologies are designed to improve patient…

Read More “Hybrid Transition & Change Management: Operating Blueprint for Scalable Decentralized Trials” »

Hybrid Transition & Change Management: Operating Blueprint for Scalable Decentralized Trials Hybrid Transition & Change Management: Operating Blueprint for Scalable Decentralized Trials In the evolving landscape of clinical research, the transition from traditional to decentralized and hybrid clinical trial models is crucial. Clinical trial management has become more complex due to diverse patient populations, technological…

Read More “Hybrid Transition & Change Management: Operating Blueprint for Scalable Decentralized Trials” »

How to Design Hybrid Transition & Change Management That Meets FDA, EMA and MHRA Expectations How to Design Hybrid Transition & Change Management That Meets FDA, EMA and MHRA Expectations As the landscape of clinical trials evolves, the need for hybrid transition and change management strategies has become increasingly significant. With regulatory oversight from agencies…

Read More “How to Design Hybrid Transition & Change Management That Meets FDA, EMA and MHRA Expectations” »

How to Design Hybrid Transition & Change Management That Meets FDA, EMA and MHRA Expectations How to Design Hybrid Transition & Change Management That Meets FDA, EMA and MHRA Expectations The design and implementation of hybrid transition and change management strategies in clinical trials have become increasingly relevant with the advent of decentralized clinical trials….

Read More “How to Design Hybrid Transition & Change Management That Meets FDA, EMA and MHRA Expectations” »

Hybrid Transition & Change Management in Practice: Step-by-Step Guide for Sponsors and CROs Hybrid Transition & Change Management in Practice: Step-by-Step Guide for Sponsors and CROs The landscape of clinical trials has undergone a significant transformation, driven by the need for adaptability and resilience in response to global challenges such as the COVID-19 pandemic. Hybrid…

Read More “Hybrid Transition & Change Management in Practice: Step-by-Step Guide for Sponsors and CROs” »

Common Pitfalls in Hybrid Transition & Change Management—and How to Avoid Compliance Risks Common Pitfalls in Hybrid Transition & Change Management—and How to Avoid Compliance Risks The adoption of decentralized and hybrid clinical trials represents a significant advancement in the landscape of clinical research, particularly in the context of COVID clinical trials. However, transitioning to…

Read More “Common Pitfalls in Hybrid Transition & Change Management—and How to Avoid Compliance Risks” »

Aligning Hybrid Transition & Change Management With GCP, Telehealth and Home-Based Care Regulations Aligning Hybrid Transition & Change Management With GCP, Telehealth and Home-Based Care Regulations The transition towards hybrid clinical trials represents a significant shift in how pharmaceutical research is conducted. Over the past few years, especially post-COVID-19, various stakeholders, including regulatory authorities like…

Read More “Aligning Hybrid Transition & Change Management With GCP, Telehealth and Home-Based Care Regulations” »